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1. Introduction
  During the last two decade, several studies have been 
performed to establish biologically active products from 
marine sources, which mostly deals with marine bacteria 
and their potential role in the production of metabolites is 
becoming thrust area for research, Sponges (Porifera) have 
been recognized as a rich source of novel compounds that 
are of potential interest to mankind[1]. Marine sponges are 
conspicuous members of the marine benthos, occurring 
worldwide from polar and temperate to tropical seas, from 
the intertidal to deep-sea environments[2]. The development 
of easy and economically feasible synthesis of bioactive 
compounds has been preferred to date by drug companies 
and many marine leads have not advanced in development 
after their chemical descriptions in the literature[3]. In 
recent years, our research have been focused on the 
isolation of cytotoxic molecules from marine sources mainly 
sponges having active secondary metabolites against broad 
spectrum of clinical and marine pathogens. Sponges are 
filter feeders, which live in areas with strong currents 
or wave action. Most carnivorous animals avoid sponges 
because of the splinter-like spicules and toxic chemicals 
produced/sequestered by the sponge. Sponges are an 
important component of the benthic fauna throughout the 
temperate, tropical, and polar habitats[4]. 
  Sponges with enormous diversity of microorganisms have 
an explicit source of pharmaceutical valued products. 
The biology of the bacteria-sponge relationship has 
been elicited considerable interest among researchers 
to investigate marine organisms as sources of natural 
products[5]. The route filter feeding offers the possibility 
of associated bacteria to produce high amounts of 
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biomass, biological active secondary metabolites. These 
metabolites can easily be produced in large amounts on a 
biotechnological scale without the necessity to harvest or 
cultivate the sponge[6]. Thus an alternative strategy targeting 
the endosymbiotic bacteria of sponges for the screening 
of bioactive natural products may prove to be an effective 
approach to come to blows emerging multi resistant clinical 
pathogens.
  The Union Territory of Lakshadweep is an archipelago 
situated in the Arabian Sea between 08曘 00’ N and 12曘 30’ N 
latitude and 71曘 00’ E and 74曘 00’ E longitude and at a 
distance of 220-440 km from the west coast of India. The 
islands have a lagoon area of about 4000 sq. km, territorial 
waters covering 20 000 sq. km, continental shelf of 4 000 sq. km
and an EEZ of 0.4 million sq. km. Hitherto, the reports on 
the sponges recorded in the Lakshadweep atolls was a 
total of 91 species referable to 30 families and 66 genera[7]. 
Therefore, the present study was targeted to isolate the 
endosymbiotic microorganisms from sponges and to evaluate 
their antagonism against clinical pathogens. The present 
investigation is the second of its kind to phylogenetic study 
of endosymbiotic microorganisms in the Lakshadweep sea 
sponges.
2. Materials and methods 
2.1. Collection and identification of sponges
  Sample was collected by snorkeling and skin diving from the 
sub-tidal habitats at depths at 3 meter at different location 
of Kavaratti (Lat. 10曘 33´ N, Long. 72曘 38´ E) islands. The 
samples were placed inside sterile ethyl polythene bags 
at the underwater itself and transferred to the laboratory, 
where they were examined and processed to isolate bacteria. 
The sponge material was preserved in 70% methanol for 
identification purpose. Identification was carried out with 
the help of Dr. P. A. Thomas, Sponge Taxonomist, Scientist 
(Retd), CMFRI, Vizhinjam, India.
2.2. Isolation of sponge associated bacteria
  Sponge sample were washed with jets of filtered and 
autoclaved sea water until they were visibly free from 
debris. Followed, the sponge surface was sterilized by a 
rapid wash of 70% ethanol and immediately immersed in 
sterilized seawater and then aspirated. One gram of sponge 
tissue was removed with a sterile scalpel and the tissue 
was immediately transferred to 99 mL sponge dissociation 
medium (2.7% NaCl, 0.008% KCl, 0.01% Na2SO4, pH 8). 
The samples are soaked for 20 min and then the tissue and 
diluents were macerated and the homogenate was spread 
on Zobell Marine agar 2216 (Himedia, Mumbai), by 50% 
sea water, using a dilution series of 10-5. The plates were 
incubated at room temperature (approx. 27-30 曟) for 3 d. 
The isolated colonies were repeatedly streaked to obtain 
pure cultures and stored in Zobell agar slants at 4 曟 for 
further studies[8].
2.3. Bacterial extracts
  Totally 7 sponge bacterial isolates (LB1 to LB7) were 
inoculated in each flask with 100 mL Zobell marine broth 
(Himedia, Mumbai) containing 500 mL Erlenmeyer flask 
in a shaker (30 曟/250 rpm) for 48-74 h and the cells were 
separated by centrifugation (4 曟/7 000 rpm/10 min) and 
supernatant was extracted using same volume of ethyl 
acetate, methanol, hexane and the solvent was removed at 
37 曟.
2.4. Preliminary screening for antibacterial activity
  The five human pathogenic bacteria namely Staphylococcus 
aureus (S. aureus), Escherichia coli (E. coli), Salmonella 
typhi (S. typhi), Klebsiella pneumoniea (K. pneumoniea) 
and Streptococcus sp. were used in this study were obtained 
from Raja Muthaiya medical college, Annamalai University, 
Tamil Nadu. The human pathogenic bacterial strains were 
grown in 50 mL of nutrient broth at 37 曟 and maintained in 
nutrient agar slant at 4 曟. An overnight suspension culture 
of the five bacterial strains was spread on the Mueller-
Hinton agar (MHA) media. Sterile discs were prepared and 
placed on the culture spread agar media. The discs were 
impregnated with sponge isolated bacterial extract and the 
commercial antibiotic chloramphenicol was included as a 
positive control to determine the sensitivity of the bacterial 
strains. The inoculated plates were incubated at 37 曟 for 
24 h. The antibacterial activity was evaluated by measuring 
diameter of the inhibition zone around the disc.
2.5. Characterization of potential LB3 isolate
2.5.1. Phenotypic Characterization
  Potential isolate of sponge associated bacteria LB3 were 
showed excellent activity against fish pathogens. The 
potential bacterial isolates were cultured on agar medium 
for 24 h at 28 曟, and its physiological and biochemical 
examination were carried out. Followed, the colony 
morphology, Gram-stained and motility was determined. 
The biochemical characters of potential bacteria was 
characterized with Biochemical kit-KB002 (Hi media, 
Mumbai) which includes Indole, Methyl red, Voges 
Proskeur’s, Citrate utilization, H2S production and sugar 
utilization tests.
2.5.2. DNA isolation and 16S rDNA gene amplification
  The potential bacteria LB3 were cultured in LB broth 
(Hi Media, Mumbai) for 2 d and total genomic DNA was 
extracted. The 16S rDNA sequences were amplified by 
polymerase chain reaction (PCR) using universal primers 
8f (3´-A GAGTTTGATCCTGTGCTCAG-5´) and 1 490r (5´-
GACTTACCAGGGTATCTAATCC-3´). PCR procedures were 
followed by the method of Kumaran  et al[9].
2.5.3. Sequencing and phylogenetic analysis
  The amplified PCR products were purified using a Genei 
PCR purification kit (Genei, Bangalore). Nearly full-
full length sequences of the amplified 16S rDNA genes
(1 510 bp) were obtained by automated sequencer (Bioserve 
Biotechnologies pvt. Limited, India). The sequences were 
edited by using Clustal X mega software and a BLAST search 
was performed in the National Center for Biotechnology 
Information (NCBI) database to identify the nearest neighbor 
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of the amplified sequence. The results of the sequencing 
were used for homology searches. Phylogenetic trees were 
inferred using the neighbor-joining method.
2.5.4.Nucleotide sequences accession number
  The partially complete (1 111 bp) 16S rDNA sequences of 
Enterobacter isolate have been deposited in the GenBank 
database under accession number HQ589912.
2.6. Determination of minimum inhibitory concentration
  In order to determining the Enterobacter sp TTAG for 
minimum inhibitory concentration (MIC) extract (2.5, 5.0, 
10.0, 20.0, 30.0, 40.0 and 50.0 mg/mL) was prepared. These 
dilutions were added to tubes containing 1 mL Muller 
Hinton broth (Himedia, Mumbai) and 30 mL of bacterial 
suspension was also added. The tubes were incubated at 37 曟
for 24 h. The MIC of the extract was determined for the 
most sensitive bacterial species. The lowest concentration 
of crude extract in broth medium that had inhibited the 
growth of the test microorganism was considered as MIC. 
Influence of crude extract on the growth inhibitory activity 
of LB3 against clinical pathogens and the OD (600 nm) was 
measured at an every hour interval compared with positive 
control without crude extract.
3. Results
  Taxonomy of sponge sample collected from Kavaratti 
island, Lakshadweep archipelago was Dysidea granulosa 
(D. granulosa) (Order: Dendroceratida, Family: Dysideidae) 
(Figure 1). In the present study, seven different types 
of bacterial colonies were isolated from D. granulosa 
central part of the organic and/or inorganic skeleton of 
sponge body and they were separated by based upon the 
colony morphology (shape, size and colour). Total count 
ranged from a highest of 2伊105 to a lowest of 3伊103 CFU per 
gram of sponge tissue. A physiological and biochemical 
characteristic of potential bacteria LB3 was Gram-negative 
rod, motile, Vp, citrate positive and sugars were fermented 
on glycerol, sucrose, raffinose and sorbitol. Oxidase, indole, 
Mr, H2S and urease showed negative.
Figure 1. Sponge sample D. granulosa isolated from Agatti island.
   Preliminary screening of bacterial extracts by disc 
diffusion assay LB3 host sponge D. granulosa have confirmed 
significant antibacterial activity strain was selected as 
potential bacteria to produce active secondary metabolites 
against clinical pathogens were S. aureus, E. coli, S. typhi, K. 
pneumoniea and Streptococcus sp. The zone of inhibition was 
compared to positive control chloramphenicol and secondary 
metabolites of LB3 which more or less similar to commercial 
antibiotic (Table 1). Crude extract obtained with ethyl 
acetate, methanol and hexane from extracellular product 
of isolated bacteria LB3 showed significant antibacterial 
activity by disc diffusion assay using 500, 1 000 and 1 500 
毺g/mL of crude extract and the minimum concentration 
of 1 000 毺g/mL shows maximum zone of inhibition against 
tested pathogens. The strain LB3 was identified by PCR 
amplification of 16S rRNA gene followed by the sequencing. 
The genomic DNA of the bacterial strain LB3 was isolated 
and confirmed by agarose gel electrophoresis. The 16S rRNA 
gene was amplified from the genomic DNA of the strain 
LB3 under the optimal conditions. Blast analysis of the 
sequence data revealed most identity with K. pneumoniae-
v-N (GenBank accession number EU360116). Molecular 
identification of the 16S rRNA gene shows 99% identity at 
100% coverage with Enterobacter sp. The sequenced 16S 
rRNA gene of strain (GenBank Accession number HQ589912) 
that was identified as 1 111 bp in length, and exhibited high 
similarity (99%) with the 16S rRNA gene of Enterobacter sp 
TTAG from GenBank database. Based on the 16S rRNA gene, 
a phylogenetic tree was generated (Figure 2). Minimum 
inhibitory concentration of Enterobacter sp TTAG have 
confirmed with lowest concentration of 5.0 mg/mL crude 
extract in broth medium against tested all clinical pathogens 
(Figure 3) after 5 h of incubation period.
Enterobacter cloacae (EF551364)
Enterobacter cloacae (JF513137)
Enterobacter sp. TTAG (HM104182)
Enterobacter cloacae (GQ426323)
Enterobacter cloacae (FN669552)
Enterobacter cloacae (HQ701802)
Enterobacter cloacae subsp. dissolven…
Enterobacter cloacae subsp. dissolven(2)
Enterobacter cloacae (EU779827)
Figure 2. Phylogenetic tree constructed through Kimura 2-parameter 
model using the Neighborhood-joining method. Queried sequence: 
Enterobacter sp. TTAG(HM104182).
Table 1
Determination of antibacterial activity of crude metabolites by disc 
diffusion method.
Clinical pathogens
Potential bacteria  (LB3) inhibition 
zone in mm diameter
S. aureus 22
E. coli 25
S. typhi 19
K. pneumoniea 22
Streptococcus sp. 23
Positive control chloramphenicol 27
Mohan Gopi et al./Asian Pacific Journal of Tropical Medicine (2012)142-146 145
S. aureus
25
20
15
10
5
0
G
ro
w
th
 (O
D
)
1   2   3   4   5   6   7    8   9  10 11 12 13 14 15
Time interval (h)
control
2.5 mg/mL
5.0 mg/mL
10.0 mg/mL
20.0 mg/mL
30.0 mg/mL
40.0 mg/mL
50.0 mg/mL
A
E. coli
16
14
12
10
8
6
4
2
0
G
ro
w
th
 (O
D
)
1   2   3   4   5   6   7    8   9  10 11 12 13 14 15
Time interval (h)
control
2.5 mg/mL
5.0 mg/mL
10.0 mg/mL
20.0 mg/mL
30.0 mg/mL
40.0 mg/mL
50.0 mg/mL
B
S. typhi
25
20
15
10
5
0
G
ro
w
th
 (O
D
)
1    2     3    4    5     6    7     8    9    10   11  12
Time interval (h)
control
2.5 mg/mL
5.0 mg/mL
10.0 mg/mL
20.0 mg/mL
30.0 mg/mL
40.0 mg/mL
50.0 mg/mL
C
K. pneumoniae
16
14
12
10
8
6
4
2
0
G
ro
w
th
 (O
D
)
1   2   3   4   5   6   7    8   9  10 11 12 13 14 15
Time interval (h)
control
2.5 mg/mL
5.0 mg/mL
10.0 mg/mL
20.0 mg/mL
30.0 mg/mL
40.0 mg/mL
50.0 mg/mL
D
Streptococcus sp
16
14
12
10
8
6
4
2
0
G
ro
w
th
 (O
D
)
1   2   3   4   5   6   7    8   9  10 11 12 13 14 15
Time interval (h)
control
2.5 mg/mL
5.0 mg/mL
10.0 mg/mL
20.0 mg/mL
30.0 mg/mL
40.0 mg/mL
50.0 mg/mL
E
 
Figure 3. Effect of crude extract against clinical pathogens was S. 
aureus, E. coli, S. typhi, K. pneumoniea and Streptococcus sp measured 
after 5 h of incubation by OD at 600 (nm) at an every hour interval.
4. Discussion
  Sponges are the oldest multicellular invertebrates, and 
they filter large quantities of seawater through their channel 
system. Bacteria, algae, phytoplankton, and fungi are the 
major components of the natural diet of sponges. Sponges 
are well known to harbor diverse microorganisms, which can 
contribute up to more than 40% of the sponge body volume 
exceeding microorganisms in seawater by two to four orders 
of magnitude[10]. The cultivable sponge-associated microbial 
diversity remains very unclear because of the difficulty in 
sponge-associated microbial isolation and pure cultivation. 
The current investigation of cultivable sponge-associated 
microbial diversity is mainly based on pure cultivation, 
single strain is isolated and cultured individually. The 
secondary metabolites secreted by endosymbionts were 
presumed to be accumulated in sponge tissue. In this 
study bacteria was isolated from sponges have been found 
to exhibit antibacterial activity meanwhile metabolites of 
sponge-associated bacteria have been determined.
  The secondary metabolites of host sponge D. granulosa 
have confirmed significant antimicrobial activity and 
inhibited the growth of clinical pathogens. As earlier 
reported by[5] seventy-five marine bacterial strains 
associated with four species of sponges (Echinodictyum sp., 
Spongia sp., Sigmadocia fibulatua and Mycale mannarensis), 
agar-overlay method was used to screen for antibiotic 
production. Comparative to other sponge isolates, the LB3 
strain inhibited the growth of all tested clinical pathogens 
assayed inducing inhibition of 25 mm in preliminary 
results. Some evidence indicates that many compounds 
previously found in sponges are biosynthesized through 
microorganisms associated with them or indeed produced 
by microorganisms[11]. Antibiotic production is subject to 
complex regulatory networks and is generally induced in 
stationary phase under conditions of nutrient limitation 
(Martin and Liras 1989). Antibacterials are thought to confer 
a selective advantage, when in competition with other 
bacteria populating for their survival in the same ecological 
niche. Minimum inhibitory concentration of LB3 was assayed 
against tested clinical pathogens have confirmed with lowest 
concentration of 5.0 mg/mL in broth medium influence 
of crude extract on growth inhibitory activity after 5 h of 
incubation period and completed the inhibitory activity at 15 h.
  Shridhar et al[12-16] reported a phenolic compound 
2-(2’,4’-dibromophenoxy)-4,6-dibromophenol was 
obtained from the sponge extracts of D. granulosa from 
Lakshadweep islands, against strains of MRSA and VRE. 
The secondary metabolite was produced by endosymbiotic 
bacteria Enterobacter sp in D. granulosa not extracted from 
sponge tissue. Thus, the 2-(2’,4’-dibromophenoxy)-4,6- 
dibromophenol may be produced by the endosymbiotic 
bacteria of D. granulosa. So instead of harvesting the whole 
sponge we could be producing the potential compound 
by culturing the microbe against fish pathogens. There is 
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now considerable evidence for the presence of a diverse 
assemblage of Enterobacter sp in the marine environment. 
Hentschel et al[17] reported the antimicrobial activities of 
marine sponges Aplysina aerophoba and A. cavernicola 
with phylogenetic analysis. The isolated bacteria showed 
conspicuous results against clinical pathogens of (S. aureus, 
E. coli, S. typhi, K. pneumoniea and streptococcus sp.). To 
our knowledge, this is the first time that a strain recovered 
genus Enterobacter sp has been isolated and cultured from 
Lakshadweep sea sponge. The 16S rRNA gene sequence of 
isolate LB3 shares 99% homology with that of K. pneumoniae, 
and is thus phylogenetically closely related to this species. 
In vitro antimicrobial screening of sponge crude extract 
showed antimicrobial activities against selected clinical 
isolates of bacteria and fungi[18]. In this regard, the present 
study implies that systemic drug development could be 
sustained using the associated endosymbionts instead of 
host sponges as an alternative of harvesting whole sponge. 
The endosymbiotic microorganisms could be stored in the 
laboratory for a long period and reactivated and/or scaled 
up using bioreactor for further studies. Even though there 
are many reports available on marine microbes for the 
metabolite production, reports on sponge endosymbionts 
particularly from Lakshadweep are very scanty. Based 
on the antibacterial activity this study concluded that 
phylogenetic analysis of endosymbiotic bacteria Enterobacter 
sp from sponge D. granulosa of Lakshadweep islands 
showed significant antibacterial activity against clinical 
pathogens. Thus, the present study is a preliminary work in 
the Lakshadweep endosymbiotic bacteria of Enterobacter sp 
TTAG and further studies are in progress in characterization 
and purification of the secondary metabolites of the host 
sponge D. granulosa.
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